Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q2 2026 holdings

Shares (Q2 2026)
3,000
Value
$5.04K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of PACB by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,000$5.04K<0.1%−101−3.3%ReducedHolders
Q1 20263,101$4.09K<0.1%+101+3.4%AddedHolders
Q4 20253,000$5.61K<0.1%00.0%UnchangedHolders
Q3 20253,000$3.84K<0.1%00.0%UnchangedHolders
Q2 20253,000$3.72K<0.1%−730−19.6%ReducedHolders
Q1 20253,730$4.40K<0.1%+466+14.3%AddedHolders
Q4 20243,264$5.97K<0.1%00.0%UnchangedHolders
Q3 20243,264$5.55K<0.1%+264+8.8%AddedHolders
Q2 20243,000$4.11K<0.1%00.0%UnchangedHolders
Q1 20243,000$11.3K<0.1%+3,000NewHolders
Q4 20230$00.0%−46−100.0%Sold outHolders
Q3 202346$384<0.1%00.0%UnchangedHolders
Q2 202346$612<0.1%00.0%UnchangedHolders
Q1 202346$533<0.1%00.0%UnchangedHolders
Q4 202246$376<0.1%00.0%UnchangedHolders
Q3 202246$00.0%00.0%UnchangedHolders
Q2 202246$00.0%−13−22.0%ReducedHolders
Q1 202259$1.00K<0.1%−44−42.7%ReducedHolders
Q4 2021103$2.00K<0.1%+89+635.7%AddedHolders
Q3 202114$00.0%−20−58.8%ReducedHolders
Q2 202134$1.00K<0.1%+25+277.8%AddedHolders
Q1 20219$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.